Madrigal Pharmaceuticals (MDGL) Property, Plant & Equipment (Net) Growth (3y) (2013 - 2026)
Powered by 
Analysis
Madrigal Pharmaceuticals (MDGL) Property, Plant & Equipment (Net) Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.26 Bn | 131.41 Bn | 2.84 Bn | 14.05% |
| 2 | Regeneron Pharmaceuticals | 85.64 Bn | 77.64 Bn | 3.93 Bn | 11.65% |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | 411.50% |
| 4 | Moderna | 57.83 Bn | 52.69 Bn | 52.00 Mn | -3.34% |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | - |
| 6 | BeOne Medicines | 39.94 Bn | 34.84 Bn | 1.53 Bn | 16.78% |
| 7 | Alnylam Pharmaceuticals | 35.19 Bn | 31.88 Bn | 992.69 Mn | 1.66% |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | - |
| 9 | Insmed | 27.35 Bn | 26.19 Bn | 358.27 Mn | 19.96% |
| 10 | Madrigal Pharmaceuticals | 15.77 Bn | 14.93 Bn | - | 194.25% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 194.25% |
| Mar 31, 2026 | 150.36% |
| Dec 31, 2025 | 35.62% |
| Sep 30, 2025 | 60.77% |
| Jun 30, 2025 | 26.97% |
| Mar 31, 2025 | 33.67% |
| Dec 31, 2024 | 37.04% |
| Sep 30, 2024 | 39.03% |
| Jun 30, 2024 | 23.91% |
| Mar 31, 2024 | 21.22% |
| Dec 31, 2023 | 14.04% |
| Sep 30, 2023 | -17.01% |
| Jun 30, 2023 | -28.88% |
| Mar 31, 2023 | -28.02% |
| Dec 31, 2022 | -20.23% |
| Sep 30, 2022 | 57.04% |
| Jun 30, 2022 | 55.21% |
| Mar 31, 2022 | 49.13% |
| Dec 31, 2021 | 55.35% |
| Sep 30, 2021 | 51.23% |